Mast cell stabilization improves survival by preventing apoptosis in sepsis

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Cytokine inhibition showed limited success in sepsis treatment due to lack of specificity.
• Mast cells (MCs) are implicated in early sepsis defense, suggesting a cellular approach may be more effective.
• Sepsis pathogenesis involves complex immune dysregulation, necessitating novel therapeutic targets.

Purpose of the Study:

• To investigate the therapeutic potential of mast cell stabilizers in sepsis.
• To elucidate the role of mast cells in sepsis-induced mortality and identify key molecular mediators.
• To determine if mast cell stabilization can prevent sepsis-associated cell death and HMGB1 release.

Main Methods:

• Utilized wild-type and mast cell-deficient mice in sepsis models.
• Administered mast cell stabilizers and assessed survival rates and serum cytokine levels (TNF, HMGB1).
• Investigated the impact of MC stabilizers on apoptosis and caspase-3 activation in sepsis.

Main Results:

• MC stabilizers improved survival in wild-type mice but not in MC-deficient mice.
• Serum HMGB1 levels strongly correlated with survival and were inhibited by MC stabilizers.
• MC stabilizers prevented apoptosis and caspase-3 activation, suggesting a mechanism involving inhibition of extracellular HMGB1 release from dying cells.

Conclusions:

• Mast cell stabilization offers therapeutic benefits in sepsis by mitigating cell death and reducing HMGB1 release.
• Mast cells play a critical role in regulating cell death pathways during sepsis.
• Mast cell stabilization represents a promising pharmacological strategy for treating sepsis and related infectious disorders.